Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study

设为首页

收藏本站

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Readers' Guide

Opening Hours
Collections
Help Via Email

Publications

Electronic Information Resources

Apheresis and intravenous immunoglobulins used in addition to conventional therapy to treat high-risk pregnant antiphospholipid antibody syndrome patients. A prospective study

详细信息查看全文

作者：Amelia Ruffatti^a ; ^{amelia.ruffatti@unipd.it" class="auth_mail" title="E-mail the corresponding author} ; Maria Favaro^a ; Ariela Hoxha^a ; Alessandra Zambon^b ; Piero Marson^c ; Teresa Del Ross^a ; Antonia Calligaro^a ; Marta Tonello^a ; Giovanni B. Nardelli^b
关键词：LMWH ; low molecular weight heparin ; LDA ; low dose aspirin ; APS ; antiphospholipid antibody syndrome ; IVIG ; intravenous immunoglobulins ; aPL ; antiphospholipid antibodies ; LAC ; lupus anticoagulant ; HELLP ; hemolysis elevated liver enzymes low platelets ; aCL ; anticardiolipin antibodies ; a-β2GPI ; anti-β2Glycoprotein I antibodies
刊名：Journal of Reproductive Immunology
出版年：2016
出版时间：June 2016
年：2016
卷：115
期：Complete
页码：14-19
全文大小：91 K

文摘

•: Conventional treatments fail in about 20% of antiphospholipid syndrome pregnancies.
•: Therapy for high-risk antiphospholipid syndrome pregnancies is not yet established.
•: Apheresis plus intravenous immunoglobulins were evaluated as a second-line therapy.
•: The combined therapy outlined here led to a high birth rate and no side-effects.